Adrenomedullin Helps Tumors Grow Blood Vessels: Angiogenesis Control in Cancer
Adrenomedullin promotes tumor angiogenesis (blood supply formation) as a tumor progression factor, with anti-adrenomedullin strategies potentially inhibiting tumor growth by cutting off blood supply.
Quick Facts
What This Study Found
Adrenomedullin functions as a tumor progression factor primarily through angiogenesis promotion — stimulating tumor blood vessel formation, supporting cancer growth, and providing a targetable vulnerability for anti-cancer strategies.
Key Numbers
How They Did This
review study on neuropeptides, cancer.
Why This Research Matters
Relevant for neuropeptides, cancer.
The Bigger Picture
Advances peptide research.
What This Study Doesn't Tell Us
See abstract.
Questions This Raises
- ?Further research needed.
- ?Clinical translation to evaluate.
Trust & Context
- Key Stat:
- Key finding Adrenomedullin functions as a tumor progression factor primarily through angiogenesis promotion — stimulating tumor blood vessel formation, supporting
- Evidence Grade:
- moderate evidence.
- Study Age:
- Published in 2006.
- Original Title:
- Adrenomedullin: a tumor progression factor via angiogenic control.
- Published In:
- Current cancer drug targets, 6(7), 635-43 (2006)
- Authors:
- Nakamura, Misa, Han, Bo(2), Nunobiki, Osamu, Kakudo, Kennichi
- Database ID:
- RPEP-01170
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
What was studied?
Adrenomedullin Helps Tumors Grow Blood Vessels: Angiogenesis Control in Cancer
What was found?
Adrenomedullin promotes tumor angiogenesis (blood supply formation) as a tumor progression factor, with anti-adrenomedullin strategies potentially inhibiting tumor growth by cutting off blood supply.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-01170APA
Nakamura, Misa; Han, Bo; Nunobiki, Osamu; Kakudo, Kennichi. (2006). Adrenomedullin: a tumor progression factor via angiogenic control.. Current cancer drug targets, 6(7), 635-43.
MLA
Nakamura, Misa, et al. "Adrenomedullin: a tumor progression factor via angiogenic control.." Current cancer drug targets, 2006.
RethinkPeptides
RethinkPeptides Research Database. "Adrenomedullin: a tumor progression factor via angiogenic co..." RPEP-01170. Retrieved from https://rethinkpeptides.com/research/nakamura-2006-adrenomedullin-a-tumor-progression
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.